Review



rabbit ythdf3  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit ythdf3
    G3BP1 interactome differs in MNV-infected cells and arsenite treated cells as addressed by immunofluorescence (A-C). BV2 GFP-G3BP1 cells were either infected with MNV (MOI 10) for 9h p.i. or treated with arsenite 0.1mM for 1h and subcellular colocalisation of candidate proteins identified by mass spectrometry as interacting with GFP-G3BP1 was addressed by immunostaining (magenta) in GFP-G3BP1 positive cells (cyan). MNV-infected cells were detected by immunostaining against dsRNA (gold), nuclei were stained with DAPI. Scale bars, 10μm, red arrows indicate example of colocalisation between GFP-G3BP1 and a candidate protein. Representative view (n = 3) of confocal analysis using staining against (A) <t>YTHDF3,</t> candidate for arsenite-induced SG only, (B) FMR1, candidate for both arsenite- and MNV-induced G3BP1 granules, (C) Rab7, candidate for MNV-induced G3BP1 granules only.
    Rabbit Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 153 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3-specific+Antibody/pmc06964919-271-23-26
    Average 96 stars, based on 153 article reviews
    rabbit ythdf3 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Norovirus infection results in eIF2α independent host translation shut-off and remodels the G3BP1 interactome evading stress granule formation"

    Article Title: Norovirus infection results in eIF2α independent host translation shut-off and remodels the G3BP1 interactome evading stress granule formation

    Journal: PLoS Pathogens

    doi: 10.1371/journal.ppat.1008250

    G3BP1 interactome differs in MNV-infected cells and arsenite treated cells as addressed by immunofluorescence (A-C). BV2 GFP-G3BP1 cells were either infected with MNV (MOI 10) for 9h p.i. or treated with arsenite 0.1mM for 1h and subcellular colocalisation of candidate proteins identified by mass spectrometry as interacting with GFP-G3BP1 was addressed by immunostaining (magenta) in GFP-G3BP1 positive cells (cyan). MNV-infected cells were detected by immunostaining against dsRNA (gold), nuclei were stained with DAPI. Scale bars, 10μm, red arrows indicate example of colocalisation between GFP-G3BP1 and a candidate protein. Representative view (n = 3) of confocal analysis using staining against (A) YTHDF3, candidate for arsenite-induced SG only, (B) FMR1, candidate for both arsenite- and MNV-induced G3BP1 granules, (C) Rab7, candidate for MNV-induced G3BP1 granules only.
    Figure Legend Snippet: G3BP1 interactome differs in MNV-infected cells and arsenite treated cells as addressed by immunofluorescence (A-C). BV2 GFP-G3BP1 cells were either infected with MNV (MOI 10) for 9h p.i. or treated with arsenite 0.1mM for 1h and subcellular colocalisation of candidate proteins identified by mass spectrometry as interacting with GFP-G3BP1 was addressed by immunostaining (magenta) in GFP-G3BP1 positive cells (cyan). MNV-infected cells were detected by immunostaining against dsRNA (gold), nuclei were stained with DAPI. Scale bars, 10μm, red arrows indicate example of colocalisation between GFP-G3BP1 and a candidate protein. Representative view (n = 3) of confocal analysis using staining against (A) YTHDF3, candidate for arsenite-induced SG only, (B) FMR1, candidate for both arsenite- and MNV-induced G3BP1 granules, (C) Rab7, candidate for MNV-induced G3BP1 granules only.

    Techniques Used: Infection, Immunofluorescence, Mass Spectrometry, Immunostaining, Staining

    Related Articles

    Cell-Signaling:

    Article Title: p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.
    Article Snippet: TP53 is a well-documented tumor suppressor gene frequently mutated in malignancies.. It has been demonstrated that the gain-offunction (GOF) mutation of p53 promotes the development and progression of cancers; however, its extrinsic oncogenic mechanisms are still poorly understood.. Herein, we found that the oncogenic effect of mutant p53 in vivo is dependent on the tumor immune microenvironment.

    Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
    Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.

    Blocking Assay:

    Article Title: METTL3-mediated m 6 A on nascent RNA coordinates translational and transcriptional programs to activate the NLRP3 inflammasome in macrophages.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies IL-1β CST Cat# 12242S ASC CST Cat# 67824S NLRP3 CST Cat# 15101S β-ACTIN HUABIO Cat# ET1702-52 GAPDH HUABIO Cat# M1310-2 GSDMD Affinity Cat# AF4012 C/EBPβ Proteintech Cat# 23431-1-AP METTL3 CST Cat# 86132S IgG CST Cat# 2729 STAT3 HUABIO Cat# HM0617 p-STAT3 HUABIO Cat# HM0617 JAK1 Proteintech Cat# 66466-1-lg JAK2 HUABIO Cat# ET1607-35 JAK3 HUABIO Cat# ET1705-1 ZFP217 Abcam Cat# ab124927 METTL14 CST Cat# 48699 WTAP Proteintech Cat# 60188-L-lg YTHDF1 Proteintech Cat#66745-L-lg YTHDF2 Proteintech Cat24744-L-AP YTHDF3 Proteintech Cat# 25537-1-AP FTO Abcam Cat# ab126605 ALKBH5 Proteintech Cat#16837-L-AP SC-35 Abcam Cat# ab11826 H3 HUABIO Cat#M1306-5 m 6 A Synaptic Systems Cat# 202 003 FITC-CD11b Biolegend Cat#557396 APC/Fire 750 -CD11c Biolegend Cat# 117351 PE-F4/80 Biolegend Cat# 565410 APC-CD45 Biolegend Cat#561018 PerCP/Cyanine5.5-CD206 Biolegend Cat#141715 Fc Block BD PharMingen Cat# 553141 Chemicals, peptides, and recombinant proteins Nuclease P1 NEB Cat# M0660S Alkaline phosphatase NEB Cat# M0525S D-glucose Aladdin Cat# 23403-54-5 Insulin Aladdin Cat# rp174360 Methylene blue SIGMA Cat# M9140 Actinomycin D MCE Cat# HY-17559 α-amanitin APExBIO Cat# A4548 Lipofectamine TM 3000 Thermofisher Cat# L3000015 RNase Inhibitor Thermofisher Cat# N8080119 Protease Inhibitor APExBIO Cat# K4002 Cycloheximide MCE Cat# HY-12320 Puromycin Solarbio Cat# P8230 (Continued on next page) 18 Cell Reports 45, 116808, January 27, 2026 .. REAGENT or RESOURCE SOURCE IDENTIFIER LPS SIGMA Cat# L2630-100MG ATP SIGMA Cat# A7699 FBS SIGMA Cat# F8318-500ML Opti-MEM TM Thermofisher Cat# 31985070 L-glutamine SIGMA Cat# G8540 MSU SIGMA Cat# U0881 NP-40 Thermofisher Cat# 28324 NaCl Sinopharm Cat# 10019308 Tris-HCl(pH = 7.0) Beyotime Cat# ST768 Sucrose SIGMA Cat# V900116 EDTA Invitrogen Cat# 15575-038 Triton X-100 SIGMA Cat# 9036-19-5 Glycerol Beyotime Cat# ST1353 DTT Beyotime Cat# ST043 Urea Macklin Cat# U820355 HEPES (pH = 7.5) Beyotime Cat# C0217 Nuclease-Free Water SIGMA Cat# W4502 Insulin Aladdin Cat# rp174360 High Fat Diet (60% cal/fat) XieTong Cat# D12492 Thinwall Polypropylene Tubes Beckman Coulter Cat# 331372 N6-Methyladenosine (Standard) MCE Cat# HY-N0086R Stattic MCE Cat# HY-13818 Critical Commercial Assays IL-1β ELISA Kit RayBio Cat# ELM-Il1β-1 IL-18 ELISA Kit HUABIO Cat# EM0034 TNFα ELISA Kit HUABIO Cat# EM0010 Dual Luciferase Reporter Gene Assay Kit Yeasen Cat# 11402ES60 Cut-Tag kit Vazyme Cat# TD901 DNA Clean Beads Vazyme Cat# N411 Cut-Run-qPCR kit Vazyme Cat# HD101 and HD103 cDNA synthesis Kit Yeasen Cat# 1139ES60 qPCR SYBR Green Master Mix Yeasen Cat# 11201ES08 Click TM EU-488 RNA synthesis kit Beyotime Cat# R0301S miRNeasy Mini Kit QIAGEN Cat# 217004 GenElute TM mRNA Miniprep Kit SIGMA Cat# MRN70-1KT Fluorescent in Situ Hybridization Kit Genepharma Cat# F40171 Glucometer Yuwell NA Digital caliper Mitutoyo NA Deposited data Datebase: PRJNA1150098 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1150098 Database: PRJNA1149668 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1149668 Database: PRJNA1369820 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1369820 Experimental Models: Cell Lines J774A.1 CTCC 400–0361 HEK293T ATCC CRL-11268 L929 Professor Qingqing Wang NA Experimental Models: mice Mouse: C57BL/6 Beijing Vital River Technology Co., Ltd NA (Continued on next page) Cell Reports 45, 116808, January 27, 2026 19

    Article Title: Identification of m1A/m6A/m5C/m7G-related genes and clusters associated with neuropathic pain
    Article Snippet: The proteins were transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, United States). .. After blocking, the membranes were incubated with the following primary antibodies: Nsun2 (1:1000, PH6626, ab-mart, Shanghai, China), Mettl3 (1:1000, 15,073-1-AP, Proteintech, Rosemont, IL, United States), Ythdf3 (1:500, 25,537-1-AP, Proteintech), FTO (1:1000, PA2776, ab-mart); Wdr4 (1:1000, PS17092, ab-mart), Eif4e (1:1000, 11,149-1-AP, Proteintech), and GAPDH (1:20000, 10,494-1-AP, Proteintech) overnight at 4 °C. .. The next day, after washing the membranes thrice with Tris-buffered saline with Tween 20 (TBST), a secondary antibody (horseradish peroxidase (HRP) goat anti-rabbit IgG, 1:5000, SA00001-2, Proteintech) was added, and the membranes were incubated for 1 h. After rinsing the membranes with TBST, the proteins were detected using ECL reagent.

    Recombinant:

    Article Title: METTL3-mediated m 6 A on nascent RNA coordinates translational and transcriptional programs to activate the NLRP3 inflammasome in macrophages.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies IL-1β CST Cat# 12242S ASC CST Cat# 67824S NLRP3 CST Cat# 15101S β-ACTIN HUABIO Cat# ET1702-52 GAPDH HUABIO Cat# M1310-2 GSDMD Affinity Cat# AF4012 C/EBPβ Proteintech Cat# 23431-1-AP METTL3 CST Cat# 86132S IgG CST Cat# 2729 STAT3 HUABIO Cat# HM0617 p-STAT3 HUABIO Cat# HM0617 JAK1 Proteintech Cat# 66466-1-lg JAK2 HUABIO Cat# ET1607-35 JAK3 HUABIO Cat# ET1705-1 ZFP217 Abcam Cat# ab124927 METTL14 CST Cat# 48699 WTAP Proteintech Cat# 60188-L-lg YTHDF1 Proteintech Cat#66745-L-lg YTHDF2 Proteintech Cat24744-L-AP YTHDF3 Proteintech Cat# 25537-1-AP FTO Abcam Cat# ab126605 ALKBH5 Proteintech Cat#16837-L-AP SC-35 Abcam Cat# ab11826 H3 HUABIO Cat#M1306-5 m 6 A Synaptic Systems Cat# 202 003 FITC-CD11b Biolegend Cat#557396 APC/Fire 750 -CD11c Biolegend Cat# 117351 PE-F4/80 Biolegend Cat# 565410 APC-CD45 Biolegend Cat#561018 PerCP/Cyanine5.5-CD206 Biolegend Cat#141715 Fc Block BD PharMingen Cat# 553141 Chemicals, peptides, and recombinant proteins Nuclease P1 NEB Cat# M0660S Alkaline phosphatase NEB Cat# M0525S D-glucose Aladdin Cat# 23403-54-5 Insulin Aladdin Cat# rp174360 Methylene blue SIGMA Cat# M9140 Actinomycin D MCE Cat# HY-17559 α-amanitin APExBIO Cat# A4548 Lipofectamine TM 3000 Thermofisher Cat# L3000015 RNase Inhibitor Thermofisher Cat# N8080119 Protease Inhibitor APExBIO Cat# K4002 Cycloheximide MCE Cat# HY-12320 Puromycin Solarbio Cat# P8230 (Continued on next page) 18 Cell Reports 45, 116808, January 27, 2026 .. REAGENT or RESOURCE SOURCE IDENTIFIER LPS SIGMA Cat# L2630-100MG ATP SIGMA Cat# A7699 FBS SIGMA Cat# F8318-500ML Opti-MEM TM Thermofisher Cat# 31985070 L-glutamine SIGMA Cat# G8540 MSU SIGMA Cat# U0881 NP-40 Thermofisher Cat# 28324 NaCl Sinopharm Cat# 10019308 Tris-HCl(pH = 7.0) Beyotime Cat# ST768 Sucrose SIGMA Cat# V900116 EDTA Invitrogen Cat# 15575-038 Triton X-100 SIGMA Cat# 9036-19-5 Glycerol Beyotime Cat# ST1353 DTT Beyotime Cat# ST043 Urea Macklin Cat# U820355 HEPES (pH = 7.5) Beyotime Cat# C0217 Nuclease-Free Water SIGMA Cat# W4502 Insulin Aladdin Cat# rp174360 High Fat Diet (60% cal/fat) XieTong Cat# D12492 Thinwall Polypropylene Tubes Beckman Coulter Cat# 331372 N6-Methyladenosine (Standard) MCE Cat# HY-N0086R Stattic MCE Cat# HY-13818 Critical Commercial Assays IL-1β ELISA Kit RayBio Cat# ELM-Il1β-1 IL-18 ELISA Kit HUABIO Cat# EM0034 TNFα ELISA Kit HUABIO Cat# EM0010 Dual Luciferase Reporter Gene Assay Kit Yeasen Cat# 11402ES60 Cut-Tag kit Vazyme Cat# TD901 DNA Clean Beads Vazyme Cat# N411 Cut-Run-qPCR kit Vazyme Cat# HD101 and HD103 cDNA synthesis Kit Yeasen Cat# 1139ES60 qPCR SYBR Green Master Mix Yeasen Cat# 11201ES08 Click TM EU-488 RNA synthesis kit Beyotime Cat# R0301S miRNeasy Mini Kit QIAGEN Cat# 217004 GenElute TM mRNA Miniprep Kit SIGMA Cat# MRN70-1KT Fluorescent in Situ Hybridization Kit Genepharma Cat# F40171 Glucometer Yuwell NA Digital caliper Mitutoyo NA Deposited data Datebase: PRJNA1150098 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1150098 Database: PRJNA1149668 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1149668 Database: PRJNA1369820 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1369820 Experimental Models: Cell Lines J774A.1 CTCC 400–0361 HEK293T ATCC CRL-11268 L929 Professor Qingqing Wang NA Experimental Models: mice Mouse: C57BL/6 Beijing Vital River Technology Co., Ltd NA (Continued on next page) Cell Reports 45, 116808, January 27, 2026 19

    Protease Inhibitor:

    Article Title: METTL3-mediated m 6 A on nascent RNA coordinates translational and transcriptional programs to activate the NLRP3 inflammasome in macrophages.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies IL-1β CST Cat# 12242S ASC CST Cat# 67824S NLRP3 CST Cat# 15101S β-ACTIN HUABIO Cat# ET1702-52 GAPDH HUABIO Cat# M1310-2 GSDMD Affinity Cat# AF4012 C/EBPβ Proteintech Cat# 23431-1-AP METTL3 CST Cat# 86132S IgG CST Cat# 2729 STAT3 HUABIO Cat# HM0617 p-STAT3 HUABIO Cat# HM0617 JAK1 Proteintech Cat# 66466-1-lg JAK2 HUABIO Cat# ET1607-35 JAK3 HUABIO Cat# ET1705-1 ZFP217 Abcam Cat# ab124927 METTL14 CST Cat# 48699 WTAP Proteintech Cat# 60188-L-lg YTHDF1 Proteintech Cat#66745-L-lg YTHDF2 Proteintech Cat24744-L-AP YTHDF3 Proteintech Cat# 25537-1-AP FTO Abcam Cat# ab126605 ALKBH5 Proteintech Cat#16837-L-AP SC-35 Abcam Cat# ab11826 H3 HUABIO Cat#M1306-5 m 6 A Synaptic Systems Cat# 202 003 FITC-CD11b Biolegend Cat#557396 APC/Fire 750 -CD11c Biolegend Cat# 117351 PE-F4/80 Biolegend Cat# 565410 APC-CD45 Biolegend Cat#561018 PerCP/Cyanine5.5-CD206 Biolegend Cat#141715 Fc Block BD PharMingen Cat# 553141 Chemicals, peptides, and recombinant proteins Nuclease P1 NEB Cat# M0660S Alkaline phosphatase NEB Cat# M0525S D-glucose Aladdin Cat# 23403-54-5 Insulin Aladdin Cat# rp174360 Methylene blue SIGMA Cat# M9140 Actinomycin D MCE Cat# HY-17559 α-amanitin APExBIO Cat# A4548 Lipofectamine TM 3000 Thermofisher Cat# L3000015 RNase Inhibitor Thermofisher Cat# N8080119 Protease Inhibitor APExBIO Cat# K4002 Cycloheximide MCE Cat# HY-12320 Puromycin Solarbio Cat# P8230 (Continued on next page) 18 Cell Reports 45, 116808, January 27, 2026 .. REAGENT or RESOURCE SOURCE IDENTIFIER LPS SIGMA Cat# L2630-100MG ATP SIGMA Cat# A7699 FBS SIGMA Cat# F8318-500ML Opti-MEM TM Thermofisher Cat# 31985070 L-glutamine SIGMA Cat# G8540 MSU SIGMA Cat# U0881 NP-40 Thermofisher Cat# 28324 NaCl Sinopharm Cat# 10019308 Tris-HCl(pH = 7.0) Beyotime Cat# ST768 Sucrose SIGMA Cat# V900116 EDTA Invitrogen Cat# 15575-038 Triton X-100 SIGMA Cat# 9036-19-5 Glycerol Beyotime Cat# ST1353 DTT Beyotime Cat# ST043 Urea Macklin Cat# U820355 HEPES (pH = 7.5) Beyotime Cat# C0217 Nuclease-Free Water SIGMA Cat# W4502 Insulin Aladdin Cat# rp174360 High Fat Diet (60% cal/fat) XieTong Cat# D12492 Thinwall Polypropylene Tubes Beckman Coulter Cat# 331372 N6-Methyladenosine (Standard) MCE Cat# HY-N0086R Stattic MCE Cat# HY-13818 Critical Commercial Assays IL-1β ELISA Kit RayBio Cat# ELM-Il1β-1 IL-18 ELISA Kit HUABIO Cat# EM0034 TNFα ELISA Kit HUABIO Cat# EM0010 Dual Luciferase Reporter Gene Assay Kit Yeasen Cat# 11402ES60 Cut-Tag kit Vazyme Cat# TD901 DNA Clean Beads Vazyme Cat# N411 Cut-Run-qPCR kit Vazyme Cat# HD101 and HD103 cDNA synthesis Kit Yeasen Cat# 1139ES60 qPCR SYBR Green Master Mix Yeasen Cat# 11201ES08 Click TM EU-488 RNA synthesis kit Beyotime Cat# R0301S miRNeasy Mini Kit QIAGEN Cat# 217004 GenElute TM mRNA Miniprep Kit SIGMA Cat# MRN70-1KT Fluorescent in Situ Hybridization Kit Genepharma Cat# F40171 Glucometer Yuwell NA Digital caliper Mitutoyo NA Deposited data Datebase: PRJNA1150098 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1150098 Database: PRJNA1149668 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1149668 Database: PRJNA1369820 This paper https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1369820 Experimental Models: Cell Lines J774A.1 CTCC 400–0361 HEK293T ATCC CRL-11268 L929 Professor Qingqing Wang NA Experimental Models: mice Mouse: C57BL/6 Beijing Vital River Technology Co., Ltd NA (Continued on next page) Cell Reports 45, 116808, January 27, 2026 19

    Magnetic Beads:

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer.
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479- 1-AP), Ythdf2 (Abcam Ab246514), and Ythdf3 (Proteintech 25537- 1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479-1-AP), Ythdf2 (Abcam Ab246514 ), and Ythdf3 (Proteintech 25537-1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621 ; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Purification:

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer.
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479- 1-AP), Ythdf2 (Abcam Ab246514), and Ythdf3 (Proteintech 25537- 1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479-1-AP), Ythdf2 (Abcam Ab246514 ), and Ythdf3 (Proteintech 25537-1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621 ; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Negative Control:

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer.
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479- 1-AP), Ythdf2 (Abcam Ab246514), and Ythdf3 (Proteintech 25537- 1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Article Title: Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer
    Article Snippet: The cells were collected, and the Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Sigma Catalog No. 17-700) was used for the RIP assay. .. Lysate cells in the RIP lysate buffer and Pre-use Magnetic Beads Protein A/G Sigma CS203178 against the target protein of interest (Mettl3 (ab195352), Ythdf1 (Proteintech 17479-1-AP), Ythdf2 (Abcam Ab246514 ), and Ythdf3 (Proteintech 25537-1-AP)) were combined for 4 h. The corresponding rabbit or Mouse IgG antibody (Normal Mouse IgG Sigma CS200621 ; Rabbit IgG Purified Sigma PP64B) was used as a negative control. ..

    Immunostaining:

    Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
    Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.

    Incubation:

    Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
    Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.

    Article Title: Identification of m1A/m6A/m5C/m7G-related genes and clusters associated with neuropathic pain
    Article Snippet: The proteins were transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, United States). .. After blocking, the membranes were incubated with the following primary antibodies: Nsun2 (1:1000, PH6626, ab-mart, Shanghai, China), Mettl3 (1:1000, 15,073-1-AP, Proteintech, Rosemont, IL, United States), Ythdf3 (1:500, 25,537-1-AP, Proteintech), FTO (1:1000, PA2776, ab-mart); Wdr4 (1:1000, PS17092, ab-mart), Eif4e (1:1000, 11,149-1-AP, Proteintech), and GAPDH (1:20000, 10,494-1-AP, Proteintech) overnight at 4 °C. .. The next day, after washing the membranes thrice with Tris-buffered saline with Tween 20 (TBST), a secondary antibody (horseradish peroxidase (HRP) goat anti-rabbit IgG, 1:5000, SA00001-2, Proteintech) was added, and the membranes were incubated for 1 h. After rinsing the membranes with TBST, the proteins were detected using ECL reagent.

    Western Blot:

    Article Title: Mutant FUS perturbs m 6 A regulation by repressing ALKBH5, while restoring m 6 A levels alleviates ALS pathology in vivo
    Article Snippet: Images were acquired using a ChemiDocTM MP Imager (Bio-Rad) and images were analyzed using Image LabTM 5.2.1 Software (Bio-Rad) 46 . .. The following antibodies were used in Western blots for protein analyses: − Rabbit anti-METTL3 monoclonal antibody (Abcam, #ab195352, 1:1000) − Rabbit anti-METTL14 polyclonal antibody (Atlas, #HPA038002, 1:1000) − Rabbit anti-ALKBH5 polyclonal antibody ABclonal A11684 1:1000 − Rabbit anti-YTHDF1 polyclonal antibody ThermoFischer A305-850A-M Scientific 1:1000 − Rabbit anti-YTHDF2 polyclonal antibody Sigma-Aldrich ABE542 1:1000 − Rabbit anti-YTHDF3 polyclonal antibody Proteintech 25537-1-AP 1:1000 − Rabbit anti-YTHDC1 polyclonal antibody (1:500 Abcam ab122340) − Rabbit anti-METTL16 polyclonal antibody (1:1000 Abcam ab185990) − Rabbit anti-MAT2A polyclonal antibody (1:500 Abcam ab122340) − Mouse anti-WTAP (D-7) monoclonal antibody Santa Cruz Biotechnology sc-374280 1:1000 − Rabbit anti-ACSL3 monoclonal antibody ABclonal A22085 1:10000 − Rabbit anti-HSPA1L polyclonal antibody ABclonal A1856 1:1000 − Rabbit anti-CAPN2 monoclonal antibody Santa Cruz Biotechnology sc-373966 − Rabbit anti-HSP70 monoclonal antibody Santa Cruz Biotechnology sc-32239 1:1000 − Rabbit anti-PPM1E monoclonal antibody ABclonal A9374 1:1000 − Rabbit anti-VGF polyclonal antibody Antibodies.com A96425 1:1000 − Rabbit anti-DYNLT3 polyclonal antibody ABclonal A16982 1:2000 − Rabbit anti-TPPP3 polyclonal antibody ABclonal A6775 1:1000 − Rabbit anti-KIF5C polyclonal antibody Proteintech 25897-1-AP 1:2000 − Rabbit anti-CRABP1 monoclonal antibody ABclonal A5434 1:1000 − Rabbit anti-DNM1 polyclonal antibody ABclonal A18563 1:2000 − Rabbit anti-CIRBP polyclonal antibody ABclonal A6080 1:1000 − Rabbit anti-MTMR9 polyclonal antibody ABclonal A13124 1:1000 − Rabbit anti-Ezrin monoclonal antibody ABclonal A19048 1:2000 − Rabbit anti-GIT1 polyclonal antibody ABclonal A15437 1:2000 − Anti-Flag M2-Peroxidase (HRP) Sigma-Aldrich A8592 1:2500 − Anti-ACTB-Peroxidase (AC-15) monoclonal antibody Sigma-Aldrich A3854 1:10000 − Rabbit anti-GAPDH (6C5) monoclonal antibody Santa Cruz Biotechnology sc-32233 1:10000 − Mouse anti-ACTININ (H-2) monoclonal antibody Santa Cruz Biotechnology sc-17829 1:10000 − Anti-GIOTTO was a gift from by Maria Grazia Giansanti (CNR Cat# Giotto_001, RRID:AB 2892585) 1:10000 − Anti-Rabbit IgG (H+L) Secondary Antibody, HRP Thermo Fisher Scientific 31460 1:10000 − Anti-Mouse IgG (H+L) Secondary Antibody, HRP Thermo Fisher Scientific 32430 1:10000 .. 100 mm plates with SK-N-BE cells carrying FUS P525L at maximum 80% confluency were washed twice with ice-cold PBS 1× (Sigma- Aldrich) and irradiated with 0.4J/ cm2 of 254 nm UV light.



    Similar Products

    94
    ABclonal Biotechnology anti ythdf3
    Anti Ythdf3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Rabbit+pAb/pmc13677005-213-0-18
    Average 94 stars, based on 1 article reviews
    anti ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti ythdf3
    Rabbit Anti Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3-specific+Antibody/pm42533115-85-81-85
    Average 96 stars, based on 1 article reviews
    rabbit anti ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech ythdf3
    Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3-specific+Antibody/pm41652220-393-18-19
    Average 96 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Genechem control ythdf3 nc lentiviruses
    Control Ythdf3 Nc Lentiviruses, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviral+particles/pm42235938-78-5-12
    Average 86 stars, based on 1 article reviews
    control ythdf3 nc lentiviruses - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Genechem ythdf3
    Ythdf3, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviral+particles/pm42036761-64-7-11
    Average 86 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology ythdf3
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Rabbit+pAb/pmc13111412-81-45-47
    Average 94 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Shanghai Genechem Ltd ythdf3 shrna lentiviruses
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3 Shrna Lentiviruses, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviruses+shrna+ythdf3/pm41881336-132-0-6
    Average 86 stars, based on 1 article reviews
    ythdf3 shrna lentiviruses - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ythdf3
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Antibody/pm41862833-75-34-36
    Average 94 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech ythdf3 antibody
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF2+Antibody/pm41803297-239-37-27
    Average 96 stars, based on 1 article reviews
    ythdf3 antibody - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    YTHDF3 is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing, Immunohistochemistry

    Silence of YTHDF3 restrain cell proliferation and migration of breast cancer cells and arrested the cell cycle. (A) Relative expression of YTHDF3 mRNA and protein after transfection of shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (B) the growth ability of MDA‐MB‐231 and MCF‐7 cells transfected with shNC and shYTHDF3 was detected by CCK‐8 assay; (C) colony formation assay was used to detect the proliferation ability of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups; (D) the cell cycle distribution of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups was detected by flow cytometry; (E) expression of cyclin D1 and CDK4 in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (F, G) transwell invasion assay was used to detect the migration ability of breast cancer cells in the shNC group and the shYTHDF3 group in MCF‐7 and MDA‐MB‐231 cells; (H) the expression of vimentin, MMP9, E‐cadherin, N‐cadherin and snail in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: Silence of YTHDF3 restrain cell proliferation and migration of breast cancer cells and arrested the cell cycle. (A) Relative expression of YTHDF3 mRNA and protein after transfection of shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (B) the growth ability of MDA‐MB‐231 and MCF‐7 cells transfected with shNC and shYTHDF3 was detected by CCK‐8 assay; (C) colony formation assay was used to detect the proliferation ability of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups; (D) the cell cycle distribution of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups was detected by flow cytometry; (E) expression of cyclin D1 and CDK4 in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (F, G) transwell invasion assay was used to detect the migration ability of breast cancer cells in the shNC group and the shYTHDF3 group in MCF‐7 and MDA‐MB‐231 cells; (H) the expression of vimentin, MMP9, E‐cadherin, N‐cadherin and snail in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Migration, Expressing, Transfection, CCK-8 Assay, Colony Assay, Flow Cytometry, Transwell Invasion Assay

    Silencing YTHDF3 caused a decrease in lactate levels and affected glycolysis. (A) Lactate levels in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) extracellular acidification rate (ECAR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (C) oxygen consumption rate (OCR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (D) relative expression levels of hexokinase‐1 (HK1), hexokinase‐2 (HK2), PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (E) protein expression levels of PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; and (F) the correlation between YTHDF3 and PFKL, PKM, LDHA and LDHB was predicted using the GEPIA website.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: Silencing YTHDF3 caused a decrease in lactate levels and affected glycolysis. (A) Lactate levels in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) extracellular acidification rate (ECAR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (C) oxygen consumption rate (OCR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (D) relative expression levels of hexokinase‐1 (HK1), hexokinase‐2 (HK2), PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (E) protein expression levels of PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; and (F) the correlation between YTHDF3 and PFKL, PKM, LDHA and LDHB was predicted using the GEPIA website.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing

    YTHDF3 regulates the glycolysis level of breast cancer through the mTOR–HIF1α–LDHA axis. (A) Relative mRNA expression of HIF1α in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) the correlation between YTHDF3 and HIF1α was predicted using the GEPIA website; (C) expression of key proteins in the mTOR–HIF1α–LDHA axis in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (D) after adding activator MHY1445, the growth ability of cancer cells in shNC and shYTHDF3 groups was detected by CCK‐8 assay; (E) the lactate level of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485; and (F) expression of proteins of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 regulates the glycolysis level of breast cancer through the mTOR–HIF1α–LDHA axis. (A) Relative mRNA expression of HIF1α in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) the correlation between YTHDF3 and HIF1α was predicted using the GEPIA website; (C) expression of key proteins in the mTOR–HIF1α–LDHA axis in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (D) after adding activator MHY1445, the growth ability of cancer cells in shNC and shYTHDF3 groups was detected by CCK‐8 assay; (E) the lactate level of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485; and (F) expression of proteins of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing, CCK-8 Assay

    YTHDF3 regulates breast cancer development through the mTOR–HIF1α–LDHA axis in vivo. (A) Tumour volumes in shNC and shYTHDF3 groups on the indicated days; (B) representative tumour images and (C) tumour weights in shNC and shYTHDF3 groups on day 63; (D) mRNA and (E) protein expression levels of YTHDF3, HIF1α and LDHA in the tumours in shNC and shYTHDF3 groups; (F) Immunohistochemical images of YTHDF3, Ki67, HIF1α and LDHA in tumours in the shNC and shYTHDF3 groups, ×100.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 regulates breast cancer development through the mTOR–HIF1α–LDHA axis in vivo. (A) Tumour volumes in shNC and shYTHDF3 groups on the indicated days; (B) representative tumour images and (C) tumour weights in shNC and shYTHDF3 groups on day 63; (D) mRNA and (E) protein expression levels of YTHDF3, HIF1α and LDHA in the tumours in shNC and shYTHDF3 groups; (F) Immunohistochemical images of YTHDF3, Ki67, HIF1α and LDHA in tumours in the shNC and shYTHDF3 groups, ×100.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: In Vivo, Expressing, Immunohistochemical staining

    YTHDF3 is associated with prognosis in several cancers. (A) Column nomogram was constructed using YTHDF3 expression levels, age, T stage, N stage, M stage and tumour stage data of breast cancer patients; (B–E) survival analysis software package was used to analyse the survival prognosis difference between patients with high and low YTHDF3 expression in BRCA, DLBC, THCA and UVM.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 is associated with prognosis in several cancers. (A) Column nomogram was constructed using YTHDF3 expression levels, age, T stage, N stage, M stage and tumour stage data of breast cancer patients; (B–E) survival analysis software package was used to analyse the survival prognosis difference between patients with high and low YTHDF3 expression in BRCA, DLBC, THCA and UVM.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Construct, Expressing, Software